These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33054391)

  • 21. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.
    Chen R; Zhang H; Tang B; Luo Y; Yang Y; Zhong X; Chen S; Xu X; Huang S; Liu C
    Signal Transduct Target Ther; 2024 May; 9(1):130. PubMed ID: 38816371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.
    Davis FM; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):623-634. PubMed ID: 30760015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional diversity of macrophages in vascular biology and disease.
    Park I; Kassiteridi C; Monaco C
    Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCB 126 induces monocyte/macrophage polarization and inflammation through AhR and NF-κB pathways.
    Wang C; Petriello MC; Zhu B; Hennig B
    Toxicol Appl Pharmacol; 2019 Mar; 367():71-81. PubMed ID: 30768972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYLD-mediated signaling and diseases.
    Mathis BJ; Lai Y; Qu C; Janicki JS; Cui T
    Curr Drug Targets; 2015; 16(4):284-94. PubMed ID: 25342597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2.
    van Tits LJ; Stienstra R; van Lent PL; Netea MG; Joosten LA; Stalenhoef AF
    Atherosclerosis; 2011 Feb; 214(2):345-9. PubMed ID: 21167486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of monocyte/macrophage polarisation by extracellular RNA.
    Cabrera-Fuentes HA; Lopez ML; McCurdy S; Fischer S; Meiler S; Baumer Y; Galuska SP; Preissner KT; Boisvert WA
    Thromb Haemost; 2015 Mar; 113(3):473-81. PubMed ID: 25589344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease.
    Schroecksnadel K; Frick B; Winkler C; Fuchs D
    Curr Vasc Pharmacol; 2006 Jul; 4(3):205-13. PubMed ID: 16842138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines.
    Kim JH; Studer RK; Sowa GA; Vo NV; Kang JD
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2253-9. PubMed ID: 18784630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
    Wolfs IM; Donners MM; de Winther MP
    Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophilin A: promising new target in cardiovascular therapy.
    Satoh K; Shimokawa H; Berk BC
    Circ J; 2010 Nov; 74(11):2249-56. PubMed ID: 20962430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.
    Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB
    Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "TRP inflammation" relationship in cardiovascular system.
    Numata T; Takahashi K; Inoue R
    Semin Immunopathol; 2016 May; 38(3):339-56. PubMed ID: 26482920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease: JACC Macrophage in CVD Series (Part 1).
    Williams JW; Giannarelli C; Rahman A; Randolph GJ; Kovacic JC
    J Am Coll Cardiol; 2018 Oct; 72(18):2166-2180. PubMed ID: 30360826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage Phenotype and Function in Different Stages of Atherosclerosis.
    Tabas I; Bornfeldt KE
    Circ Res; 2016 Feb; 118(4):653-67. PubMed ID: 26892964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fuel for thought: immunometabolism is a paradigm shift in understanding immunity in cardiovascular disease.
    Caligiuri G; Norata GD
    Cardiovasc Res; 2019 Jul; 115(9):1383-1384. PubMed ID: 31199480
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.
    Aryal B; Suárez Y
    Vascul Pharmacol; 2019 Mar; 114():64-75. PubMed ID: 29551552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic features of macrophages in inflammatory diseases and cancer.
    Na YR; Je S; Seok SH
    Cancer Lett; 2018 Jan; 413():46-58. PubMed ID: 29100962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.